Updated
Updated · The New York Times · Jun 5
Columbia Scientists Precisely Edit Human Embryo DNA With 1-Letter Changes
Updated
Updated · The New York Times · Jun 5

Columbia Scientists Precisely Edit Human Embryo DNA With 1-Letter Changes

2 articles · Updated · The New York Times · Jun 5

Summary

  • Columbia researchers used base editing to alter DNA in early human embryos with unprecedented precision, replacing single genetic letters rather than cutting the genome.
  • That approach aims to avoid the damage often seen with earlier CRISPR methods and could eventually help repair disease-causing mutations before birth.
  • Dieter Egli, the geneticist who led the work, said major questions about harmful side effects remain and stressed the technique is not ready for clinical use.
  • The advance also revives a long-running ethical fight because the same technology could be used not only to prevent disease but to select desired traits in future babies.
  • The study has been posted online and is still under journal review, while Egli called for a broader public debate over altering embryonic DNA.

Insights

Will gene editing create a new class of enhanced humans accessible only to the rich?
Is it more ethical to edit a 'defective' embryo than to discard it?